The Association of the British Pharmaceutical Industry (ABPI) and the Bioindustry Association (BIA) have entered a new partnership to boost the manufacturing of medicines in Britain.
The union, entitled Medicines Manufaturing Industry Partnership (MMIP), is aimed at attracting innovative manufacturing to the UK.
Led by Ian McCubbin, senior vice president for North America, Japan and global pharma supply chain at GlaxoSmithKline, the steering group will include involvement from the Knowledge Transfer Network, AstraZeneca and Actavis.
BIA CEO Steve Bates said: “The UK’s research and development capabilities are world class and we are now seeking to put medicines manufacturing on a similar footing.”
Work will begin with KTN and MMIP working together to establish current UK funding mechanisms that can facilitate the UKs position in the medicines manufacturing market.
Technology, fiscal, regulatory and skills areas will be targeted by the team as a means to promoting the benefit of manufacturing medicines in the UK globally.
